文献速递结核与非结核分枝杆菌

活动性结核全疗程利福平浓度:性别与BMI的影响

Rifampicin concentrations throughout the entire treatment duration of active tuberculosis; impact of sex and body mass index.
PubMed 文献 · J Antimicrob Chemother · 2025-01-01

线性混合模型分析显示治疗周次与利福平浓度无显著相关,但男性浓度显著低于女性(中位差值-4.3 µg/mL,P<0.001),低体重患者显著低于正常体重者(中位差值-4.1 µg/mL,P=0.002)。35/206次测量(17%)低于推荐浓度8 µg/mL。

要点

  • 活动性结核全疗程中利福平浓度无显著周次变化。
  • 男性利福平浓度显著低于女性,中位差值-4.3 µg/mL(P<0.001)。
  • 低体重患者利福平浓度显著低于正常体重者,中位差值-4.1 µg/mL(P=0.002)。

核心结论

  • 活动性结核治疗全程利福平浓度无显著变化,但性别和BMI与利福平浓度相关。

主要发现

  • 个体内利福平浓度在整个治疗期间波动较大,但治疗周次与浓度无显著相关。
  • 男性利福平浓度显著低于女性,中位差值-4.3 µg/mL(P<0.001),中位剂量13 mg/kg。
  • 女性浓度随时间呈下降趋势,男性呈上升趋势。
  • 低体重患者利福平浓度显著低于正常体重者,中位差值-4.1 µg/mL(P=0.002)。
  • 35/206次测量(17%)的利福平浓度低于推荐水平8 µg/mL;6个月随访期间无复发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Rifampicin is a crucial part of an effective tuberculosis (TB) treatment. It has complicated pharmacokinetics (PK) with auto-induction and nonlinearity. Our objectives were to examine rifampicin concentrations throughout the entire treatment duration in individuals with active TB and to determine correlations between rifampicin concentrations, sex at birth, and body mass index (BMI). METHODS: We measured concentrations at 2-3 h post-dose (C2h) in an attempt to capture peak concentrations of rifampicin at treatment weeks 2, 4, 8, and subsequently every fourth week throughout the treatment period in patients with active TB. Linear mixed modelling was performed to analyse correlations between rifampicin concentration, week of treatment, sex at birth, and BMI. RESULTS: Forty-two participants were included, resulting in a total of 230 rifampicin concentration measurements. The intra-individual concentrations varied substantially throughout treatment but there was no correlation between week of treatment and rifampicin concentration. The concentration levels were significantly lower in men than in women, median difference -4.3 µg/mL (P < 0.001), median dose 13 mg/kg. Over time, women had a trend of decreasing concentrations and men an increasing trend. Underweight patients had significantly lower concentrations than normal weight individuals, median difference -4.1 µg/mL (P = 0.002). Rifampicin concentrations were below the recommended level of 8 µg/mL in 35/206 measurements (17%). No relapses occurred during 6 months of follow-up. CONCLUSIONS: We found no significant changes in rifampicin concentrations during TB treatment. Both sex and BMI were associated with rifampicin concentrations.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Samuelsson T, Lönnermark E, Sundell J, et al. Rifampicin concentrations throughout the entire treatment duration of active tuberculosis; impact of sex and body mass index. J Antimicrob Chemother. 2025. PMID: 40836859. doi:10.1093/jac/dkaf300

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。